Asif Alavi

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

Corey Cutler, Stephanie J. Lee, Sally Arai et al. · Blood · 2021 · 327 citations · Full text

Life Sciences, Immunology, Surgery +9

Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease

Samuel Lessard, Pauline Rimmelé, Hui Ling et al. · Scientific Reports · 2024 · 19 citations · Full text

Medicine, Genetics, Hematology +16

Initial Results from the BEACON Clinical Study: A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients with Sickle Cell Disease with Severe Vaso-Occlusive Crises

Ashish O. Gupta, Akshay Sharma, Haydar Frangoul et al. · Blood · 2024 · 16 citations

Life Sciences, Biotechnology, Hematology +16

Minimal Residual Disease as a Predictive Factor for Relapse after Allogeneic Hematopoietic Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia in First and Second Complete Remission

Rada M. Grubovikj, Asif Alavi, Ahrin Koppel et al. · Cancers · 2012 · 15 citations · Full text

Medicine, Hematology, Oncology +16

Interim Safety and Efficacy Results from a Phase 1/2 Study of Zinc Finger Nuclease-Modified Autologous Hematopoietic Stem Cells for Sickle Cell Disease (PRECIZN-1)

Asif Alavi, Mehrdad Abedi, Suhag Parikh et al. · Blood · 2022 · 15 citations

Medicine, Biotechnology, Hematology +11